The bulk of the currently available evidence of a potential anticancer activity of cannabis comes from preclinical models, ranging from cancer cell lines in culture to genetically engineered mice. Overall, these studies have reported that THC, as well as other cannabinoids (either natural or synthetic), can bind to and activate cannabinoid receptors (type 1 [CB1] and/or type 2 [CB2]) located on the surface of cancer cells, thereby modulating intracellular signaling pathways […]

This document focuses on priority areas for medicinal cannabis-related research. The authors, an international group of cannabis experts, have compiled this list, based on their extensive cannabinoid research experience.

Cannabidiol (CBD) oils are low tetrahydrocannabinol products derived from Cannabis sativa that have become very popular over the past few years. Patients report relief for a variety of conditions, particularly pain, without the intoxicating adverse effects of medical marijuana.

Cannabis has long been known to limit or prevent nausea and vomiting, lack of appetite, and pain. For this reason, cannabinoids have been successfully used in the treatment of some of the unwanted side effects caused by cancer chemotherapy. Besides their palliative effects, research from the past two decades has demonstrated their promising potential as antitumor agents in a wide variety of tumors […]